MARASCA, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.085
AS - Asia 14.759
EU - Europa 12.384
SA - Sud America 1.851
AF - Africa 290
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 22
Totale 60.444
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.584
GB - Regno Unito 4.408
HK - Hong Kong 3.691
SG - Singapore 3.554
CN - Cina 3.363
IT - Italia 2.267
VN - Vietnam 1.512
BR - Brasile 1.414
SE - Svezia 1.221
DE - Germania 1.029
FI - Finlandia 920
BD - Bangladesh 663
RU - Federazione Russa 571
UA - Ucraina 526
FR - Francia 445
TR - Turchia 432
KR - Corea 308
IN - India 289
CA - Canada 268
ID - Indonesia 222
BG - Bulgaria 212
AR - Argentina 134
NL - Olanda 130
MX - Messico 110
IQ - Iraq 107
JP - Giappone 103
ES - Italia 90
IE - Irlanda 89
EC - Ecuador 75
PL - Polonia 73
ZA - Sudafrica 71
PK - Pakistan 70
CZ - Repubblica Ceca 67
AE - Emirati Arabi Uniti 60
CL - Cile 59
BE - Belgio 55
AT - Austria 52
PH - Filippine 51
AU - Australia 50
VE - Venezuela 48
CO - Colombia 46
MA - Marocco 46
LT - Lituania 41
MY - Malesia 39
KE - Kenya 34
UZ - Uzbekistan 34
SA - Arabia Saudita 33
TN - Tunisia 29
JM - Giamaica 27
DZ - Algeria 26
EG - Egitto 26
PY - Paraguay 26
RO - Romania 26
IR - Iran 24
AZ - Azerbaigian 22
CH - Svizzera 20
JO - Giordania 20
BZ - Belize 19
CR - Costa Rica 19
TW - Taiwan 18
IL - Israele 17
PE - Perù 17
SK - Slovacchia (Repubblica Slovacca) 17
BO - Bolivia 16
NP - Nepal 16
EU - Europa 15
DK - Danimarca 14
ET - Etiopia 14
UY - Uruguay 14
PT - Portogallo 13
RS - Serbia 13
AL - Albania 12
LB - Libano 11
SI - Slovenia 11
DO - Repubblica Dominicana 10
QA - Qatar 10
TH - Thailandia 10
BY - Bielorussia 9
CY - Cipro 9
KZ - Kazakistan 9
SN - Senegal 9
GR - Grecia 8
GT - Guatemala 8
HN - Honduras 8
OM - Oman 8
PS - Palestinian Territory 8
BH - Bahrain 7
LK - Sri Lanka 7
LV - Lettonia 7
SY - Repubblica araba siriana 7
EE - Estonia 6
KG - Kirghizistan 6
KW - Kuwait 6
MD - Moldavia 6
NG - Nigeria 6
PA - Panama 6
PR - Porto Rico 6
AO - Angola 5
HU - Ungheria 5
MK - Macedonia 5
Totale 60.359
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.663
Fairfield 3.249
Southend 3.187
Ashburn 3.173
Santa Clara 2.421
Singapore 2.226
Woodbridge 1.879
Ann Arbor 1.651
Houston 1.495
Chandler 1.448
Seattle 1.262
Wilmington 1.070
Cambridge 1.018
Hefei 984
Jacksonville 975
San Jose 864
Dearborn 839
Nyköping 746
Helsinki 703
London 650
Beijing 591
Los Angeles 550
Ho Chi Minh City 502
Council Bluffs 489
Chicago 470
New York 453
Modena 427
The Dalles 333
Hanoi 318
San Diego 303
Seoul 292
Milan 266
Buffalo 263
Princeton 247
Izmir 228
Sofia 209
Lauterbourg 193
Eugene 189
Munich 185
Salt Lake City 184
Moscow 157
Jakarta 155
Dallas 133
Shanghai 132
São Paulo 121
Fremont 112
Rome 106
Frankfurt am Main 97
Tampa 97
Columbus 92
Bologna 91
Bremen 90
Orem 85
Dublin 83
Boardman 80
Elk Grove Village 80
Redwood City 79
Tokyo 78
Phoenix 77
Toronto 72
Da Nang 70
Des Moines 65
Haiphong 63
Atlanta 62
Montreal 62
Brooklyn 57
Dong Ket 57
Miami 55
Warsaw 53
Brussels 50
Guangzhou 50
Nuremberg 50
Chennai 49
Falls Church 49
Baghdad 45
Lancaster 45
Kent 43
Norwalk 43
Brno 42
Denver 41
Rio de Janeiro 41
Philadelphia 40
Kunming 36
Stockholm 36
Miano 35
San Francisco 35
Naples 34
Turku 33
Las Vegas 32
Amsterdam 31
Johannesburg 31
Kilburn 31
Parma 31
Mexico City 30
Nanjing 30
Tashkent 30
Vancouver 30
Boston 29
Dulles 29
Redondo Beach 29
Totale 43.916
Salva come PNG Salva come JPEG
Nome #
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features. 827
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 592
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study) 583
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 436
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 429
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 422
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 420
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 408
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 399
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 389
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 382
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 371
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 371
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 369
Mucorales-specific T cells in patients with hematologic malignancies 363
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 363
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 358
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 358
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 355
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 354
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 354
Chronic myeloid leukemia with thrombocythemic onset may be associated with different BCR/ABL variant transcripts 347
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 347
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 346
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 345
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials 345
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 342
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 342
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
3 CASES OF HUMAN HERPESVIRUS-6 LATENT INFECTION - INTEGRATION OF VIRAL GENOME IN PERIPHERAL-BLOOD MONONUCLEAR CELL-DNA 338
The genetics of nodal marginal zone lymphoma 328
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 327
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 326
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. 325
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: The growing saga of the IGHV3 subgroup gene usage 325
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 325
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 324
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 322
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 321
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 321
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 319
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 318
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia 317
Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience 315
Missense mutations in the PML/RAR alpha ligand binding domain in ATRA-resistant As2O3 sensitive relapsed acute promyelocytic leukemia 312
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 311
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 311
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma 310
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. 308
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 308
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 307
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 304
Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life Experience 303
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 300
Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance 299
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 298
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 298
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 296
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 296
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. 295
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma 294
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding 294
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 293
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 291
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 291
Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study 291
P53 GENE POINT MUTATIONS IN RELATION TO P53 NUCLEAR-PROTEIN ACCUMULATION IN COLORECTAL CANCERS 290
Additional neoplasms and HCV infection in low-grade lymphoma of MALT type 289
Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia 287
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 286
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival 286
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 286
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL 285
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 283
INCIDENCE AND SURVIVAL OF MYELOID MALIGNANCIES IN 1102 PATIENTS IN PROVINCE OF MODENA, NORTHERN ITALY 282
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 282
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 282
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. 282
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 282
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 281
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 281
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 280
Peripheral lymphadenopathy: role of excisional biopsy in differential diagnosis based on a five-year experience. 278
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes 277
Distinct genomic events in the myeloid and lymphoid lineages in simultaneous presentation of chronic myeloid leukemia and B-chronic lymphocytic leukemia 276
Strikingly homologous immunoglobulin gene rearrangements and poor outcome inV(H)3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status 276
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 276
Randomized phase 2 study: Elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM 275
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 273
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 273
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells 272
Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo 271
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 271
Molecular prediction of durable remission after first-line fludarabinecyclophosphamide-rituximab in chronic lymphocytic leukemia 271
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 270
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity 270
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 269
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study 268
Severe anemia in a patient with multiple sclerosis treated with natalizumab 267
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 266
Totale 32.561
Salva come PNG Salva come JPEG
Categoria #
all - tutte 237.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 237.859
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021362 0 0 0 0 0 0 0 0 0 0 0 362
2021/20224.275 197 548 517 206 99 235 259 192 398 307 698 619
2022/20234.255 503 482 325 374 579 570 81 445 488 51 190 167
2023/20242.972 104 162 172 272 562 270 349 452 54 68 188 319
2024/202510.787 313 123 141 682 1.580 1.278 624 450 2.867 445 985 1.299
2025/202619.246 1.227 1.274 1.683 2.054 2.619 1.259 2.284 924 1.739 1.613 1.624 946
Totale 60.987